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Background: Residing remotely from health care resources appears to impact quality of care delivery. It remains
unclear if there are differences in vascular access based on distance of one’s residence to dialysis centre at time of
dialysis initiation, and whether region or duration of pre-dialysis care are important effect modifiers.
Methods: We studied the association of distance from a patients’ residence to the nearest dialysis centre and
central venous catheter (CVC) use in an observational study of 26,449 incident adult dialysis patients registered in
the Canadian Organ Replacement Registry between 2000–2009. Multivariate logistic regression was used to assess
the association between distance in tertiles and CVC use, adjusted for patient demographics and comorbidities.
Geographic region and duration of pre-dialysis care were examined as potential effect modifiers.
Results: Eighty percent of patients commenced dialysis with a CVC. Incident CVC use was highest among those
living > 20 km from the dialysis centre (OR 1.29 (1.24-1.34)) compared to those living < 5 km from centre. The
length of pre-dialysis care and geographic region were significant effect modifiers; among patients residing in the
furthest tertile (>20 km) from the nearest dialysis centre, incident CVC use was more common with shorter length
of pre-dialysis care (< 1 year) and residence in central regions of the country.
Conclusion: Residing further from a dialysis centre is associated with increased CVC use, an effect modified by
shorter pre-dialysis care and the geographic region of the country. Efforts to reduce geographical disparities in pre
dialysis care may decrease CVC use.
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Vascular access is a major contributor to overall morbid-
ity and mortality in the hemodialysis population [1-5].
Central venous catheters (CVCs) are increasingly used
as the first-line vascular access in incident hemodialysis
patients [6,7]. Mortality risk in those commencing
hemodialysis with a CVC has been reported as six times
greater than the risk of death in arteriovenous fistula
(AVF) or arteriovenous graft (AVG) use combined [8].
Evidence informed guidelines statements suggest that a
functioning reliable AVF is the preferred vascular access
because it has the lowest rate of infection, access* Correspondence: lmiller@hsc.mb.ca
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reproduction in any medium, provided the orthrombosis, salvage interventions, and mortality com-
pared with the CVC and AVG [1-5,8-11].
Many patients with chronic kidney disease (CKD) and
end stage renal disease (ESRD) live in rural and remote
communities, where there are no dialysis centres or local
access to nephrology and surgical care. In the general
population, there is growing evidence supporting an as-
sociation between residence location and access to care,
where rural residents receive less optimal health care
and have overall poorer health compared to urban resi-
dents [12-17]. Less is known about the CKD and ESRD
population residing in rural and remote locations; how-
ever, an association with increased mortality and poor
achievement of evidence-based quality indicators has
been shown [18-20]. Areas for intervention and im-
provement in rural populations are often difficult to
identify, costly and resource intensive [21,22].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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quires multiple steps, including timely nephrology and
surgical assessment and access creation with sufficient
time for maturation and/or facilitative intervention as
required. Furthermore the likelihood of dialysis initiation
with an AVF varies based on the geographic region of
the country and the presence and duration of pre-
dialysis care [23,24]. Residing remotely may negatively
impact this necessary sequence of events, often resulting
in the need for dialysis initiation with a CVC. This study
examines the association between distance from patients’
residence to the nearest dialysis treatment centre and in-
cident CVC use, and whether the length of pre-dialysis
care and geographic region were effect modifiers.
Methods
Study design
This study was approved by the Research Board and
the Hospital Ethics Board at St. Boniface Hospital in
Winnipeg, Manitoba. All adults (>18 years old) who ini-
tiated chronic hemodialysis with a documented vascular
access type and registered in the Canadian Organ Re-
placement Registry (CORR) between January 1, 2000
and December 2009 (excluding Quebec) were included
in our analysis and followed until April 2011. Patients
with less than 90 days follow up from dialysis initiation
were excluded. Residents of Quebec were excluded be-
cause special permissions to use their data were not ob-
tained. The CORR is a validated national registry that
records the incidence, prevalence and outcome of all
chronic dialysis and solid organ transplant patients in
Canada [25]. Data including demographics, comorbidi-
ties, dialysis modality, vascular access status, transplant-
ation, and death is prospectively collected by voluntary
completion of survey forms for each patient at dialysis
initiation and updated annually on October 31 of each
year.
Definitions
Incident vascular access was defined as the access used
at the first hemodialysis treatment and categorized as ei-
ther CVC or AVF/G. Grafts encompassed < 5% of total
vascular accesses, and were included as one category
(AVF/G). CVCs included both tunneled cuffed and tem-
porary CVCs. Patients using a CVC with a maturing
AVF/G were included in the CVC group.
Distance to centre was calculated as the direct linear
distance in kilometers (km) between a patient’s postal
code of their primary residence at dialysis initiation to
the nearest dialysis centre using Vincenty’s formula, a
validated iterative method to calculate the distance be-
tween two points, while accounting for the Earth’s
curvature [26]. Distance was divided into tertiles < 5 km,
5–20 km, and > 20 km. Pre-dialysis care was defined aswhether or not patients had their first contact with a
nephrologist > 90 days prior to the initiation of hemodialysis
therapy. Duration of pre-dialysis care was the time between
first contact with a nephrologist and initiation of first dialy-
sis. This information is collected on the CORR data collec-
tion form at time of initiation of dialysis. Race was based on
patients’ self report. Co-morbid illnesses included a history
of angina, myocardial infarction, coronary artery by-
pass surgery, diabetes mellitus, peripheral vascular dis-
ease, malignancy, hypertension, cigarette smoking, lung
disease, cerebral vascular disease (CVD), and any serious
illness. Comorbidities and laboratory data were ascer-
tained at the start of dialysis. Causes of ESRD included
hypertension, diabetes mellitus, glomerulonephritis, inter-
stitial disease, polycystic kidney disease, obstruction, other
and unknown. Provinces and territories were categorized as
geographic regions as follows: Atlantic (New Brunswick,
Nova Scotia, Prince Edward Island, Newfoundland),
Central (Ontario), Prairies (Alberta, Saskatchewan,
Manitoba, Nunavut, Northwest Territories), Pacific
(British Columbia, Yukon).
Outcome measures
The outcome of interest was incident CVC usage in the
hemodialysis cohort. Incident access was determined at
dialysis initiation.
Statistical analyses
Continuous variables were summarized as means or me-
dians with standard deviation or inter-quartile ranges,
respectively depending on their data distribution. Differ-
ences in baseline characteristics between distant cohorts
were determined by the Z test, students t-test or the
Kruskal Wallis test for continuous variables and chi-
square or the Mann–Whitney test for dichotomous vari-
ables, according to the data distribution.
To assess our outcome of incident CVC usage, we cre-
ated separate multivariate logistic regression models ad-
justed for the distance from centre, demographics such as
age, sex, race, dialysis era, pre-dialysis care, geographic re-
gion, comorbidities, BMI, cause of ESRD and initial la-
boratory investigations (serum albumin, hemoglobin).
Distance from the centre was modeled as a continuous
variable but categorized into tertiles as < 5, 5–20 and >
20 km from the closest dialysis centre. Formal interaction
terms were examined for effect modification.
To examine the relationship between pre-dialysis care
and distance to centre, the interaction of distance to
centre and the binary presence/absence of pre-dialysis
care was first determined. The analysis was then limited
to those who received pre-dialysis care (nephrologist
contact > 90 days before dialysis initiation) and catego-
rized by duration of care < 1, 1–3 and > 3 years. Similarly
the impact of distance to centre and incident vascular
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formal interaction term of region and distance.
Multiple imputation [27] was employed for missing
values for BMI (9.2%), pre-dialysis care (17%), etiology of
ESRD (3.7%), co-morbidities(2.3%), hemoglobin(8.3%),
and albumin(15.3%) with a random draw from the pre-
dictive distribution of an imputation model including
age, sex, and race, repeated ten times. An iterative
Markov chain Monte Carlo (MCMC) method was used.
Separate models were created using original and im-
puted data, and as no statistically significant differences
were noted, pooled estimates of 10 iterations were
reported.
Analyses were performed using PASW Version 18. All
hypothesis tests were two sided with statistical signifi-
cance defined as having a P value of <0.05.
Results
Patient characteristics stratified by distance from nearest
dialysis provider
The original study cohort consisted of 29,406 patients
with known vascular access (96% of all incident patients),
but 2378 were excluded due to follow-up < 90 days after
initiation of dialysis, and 579 were excluded due to miss-
ing distance data. Our study cohort consisted of 26, 449
incident hemodialysis patients with known vascular access
(CVC 79.8%, AVF 20.2%) at initiation of dialysis between
January 2001 and December 2009 in the CORR database.
Female sex, co-morbid illnesses (diabetes, myocardial in-
farction, CABG, pulmonary edema, malignancy, any ser-
ious illness) were associated with incident CVC use
whereas increasing age, hemoglobin, albumin, BMI and
hypertension were associated with incident AVF/AVG
(data not shown). Patients residing > 20 km from a dialysis
centre were more likely to be younger, either Caucasian or
Aboriginal, have a higher BMI and reside in the Atlantic
or Prairie provinces (Table 1). There were no substantive
differences in co-morbidities based on distance, however
less ESRD due to hypertension was seen in those residing
> 20 km. Mean albumin, mean hemoglobin, the propor-
tion receiving pre-dialysis care and the duration of pre-
dialysis care were all lower in those residing > 20 km. Al-
though rates of CVC use at start of dialysis were high
overall, patients who resided > 20 km from the nearest
dialysis centre had higher CVC usage (82.3%) than pa-
tients who lived < 5 km (79.7%) and 5–20 km (78.1%)
(Table 1).
Association of distance and incident catheter use
Distance was significantly associated with incident CVC
use in adjusted models (p < 0.0001) (Table 2). In compari-
son to patients living within 5 km of a dialysis centre, pa-
tients living > 20 km away were almost 30% more likely to
initiate dialysis with a CVC after adjustment for covariatesincluding age, race, sex, BMI, albumin, hemoglobin,
co-morbidities, region, and pre-dialysis care (OR 1.29
(95% CI 1.0-1.34)).
Association of vascular access, distance and pre-dialysis
care
We examined whether pre-dialysis care and geographic
region were effect modifiers on the relationship between
vascular access and distance. Overall, patients who did
not receive any pre-dialysis care were more likely to re-
ceive dialysis by a CVC. In patients without any pre-
dialysis care, those residing > 20 km from the nearest
dialysis centre were more than 3 times as likely to initi-
ate dialysis with a CVC compared to those residing <
5 km (OR 3.64 (95% CI 2.62-5.07))(Table 3). Even among
patients with pre-dialysis care, residing > 20 km was as-
sociated with CVC use at dialysis initiation compared to
residing < 5 km (OR 2.42 (2.16-2.71)).
The duration of pre-dialysis care was a significant ef-
fect modifier, where longer duration of pre-dialysis care
partially attenuated the impact of distance. In patients
with the shortest duration of pre-dialysis care (<1 year),
those residing furthest away ( > 20 km) were more likely
to commence dialysis with a CVC than those residing <
5 km (OR 1.27 (95% CI 1.05-1.54)) (Table 4). But within
the patients who lived furthest away (> 20 km), incident
CVC use decreased with longer pre-dialysis care (72%
CVC >3 years vs 82.5% relative <1 year). Overall, pa-
tients with > 3 years pre-dialysis care residing > 20 km
away from a dialysis were 30% less likely to start HD
with a CVC than those with <1 year pre-dialysis care liv-
ing within 5 km of a dialysis unit (OR 0.71 (0.60-0.84)).
The relationship between CVC use and distance from
dialysis centre varied across regions in Canada (distance
X geographic region p value = 0.002) (Table 5). Residing
remotely strongly increased the likelihood of initiating
with a CVC in the Atlantic and Central regions of
Canada; this effect was attenuated or absent in the Prai-
ries or Pacific regions. This was especially marked in the
central region (Central OR of CVC 1.31 (95% CI 1.03-
1.67), p < 0.0001 and 1.93 (95% CI 1.55-2.4), p < 0.001,
respectively, referent Atlantic region < 5 km).
Discussion
Vascular access represents one of the most modifiable fac-
tors for improving dialysis adequacy and outcomes. Cath-
eter use is associated with higher morbidity and mortality
risk than AVF use. In this large, national cohort study we
demonstrated that living further from a dialysis centre was
independently associated with incident CVC use. Pre-
dialysis care and geographic region were significant effect
modifiers on the relationship between distance and CVC
use. Taken together, these results highlight the negative ef-
fect of residing remotely from health care resources in
Table 1 Baseline characteristics by distance from
residence postal code and nearest dialysis facility (% or
mean ± SD)
< 5 km 5-20 km >20 km
% (N) % (N) % (N)
N 27.2(7192) 35.1(9287) 37.7(9970)
CVC* 79.7 (5659)a 78.1(7251)a 82.3(8202)b
AVF/AVG** 21.3(1533)a 21.9(2036)a 17.7(1768)b
Age p < 0.001 67.5(14.9) 66.2(15.3) 64.8(15.0)
Sex (% female) 41.9(3012)a 40.3(3740)b 40.4(4027)a,b
Race
Caucasian 69.7(5014)a 68.1(6324)a 78.0(7780)b
Aboriginal 4.9(349)a 1.8(170)b 11.4(1139)c
East Asian 7.4(534)a 9.1(842)b 1.8(182)c
South Asian 9.9(710)a 11.9(1101)b 6.5(649)c
Black 4.0(297)a 4.8(448)b 1.1(108)c
Other 4.0(288)a 4.3(402)a 1.1(112)b
BMI p < 0.0001 27.4(7.0) 27.7(7.1) 28.1(7.1)
Geographic location
Atlantic 21.8(609)a 22.3(622)b 55.9(1560)c
Central 29.1(4196)a 38.3(5462)a 32.6(4647)b
Prairie 24.9(1495)a 32.6(1955)a 42.5(2550)b
Pacific 27.7(942)ab 36.7(1248)b 35.6(1213)a
Co-morbidities




Pulmonary edema 27.0(1940)a 24.7(2298)b 27.5(2738)b
Diabetes mellitus 48.7(3500)a 46.3(4299)b 48.1(4792)a




Malignancy 11.5(828)b 10.6(1149)a 12.7(1264)a
Lung disease 12.1(924)a 10.9(1180)b 12.9(1178)a
Hypertension 83.1(5977)a 82.5(7665)a,b 82.3(8207)b
Serious Illness 11.2(809)a 11.1(1034)a 10.4(1036)a
Current smoker 13.3(959)a 11.0(1017)b 15.6(1557)c
CABG 13.3(954)a 13.8(1282)a 13.6(1355)a
Cause of ESRD:
Hypertension 23.9(1718)a 22.9(2476)a 21(1918)b
Diabetes mellitus 39.0(2807)a 36.1(3909)b 38.4(3514)a
Glomerulonephritis 12.6(906)a 14.9(1611)b 14.8(1355)b
Obstruction 3.0(213)a 3.8(409)b 3.9(354)b




Other 7.0(504)a 7.7(713)a,b 8.1(808)b
Unknown 10.6(765)a 9.7(905)a 8.9(883)b
Table 1 Baseline characteristics by distance from
residence postal code and nearest dialysis facility (% or
mean ± SD) (Continued)









Pre-HD care < 1 year+ 27.9(1652)a 34.8(2057)a 37.3(2203)a
Pre-HD care 1–3 years+ 28.0(1561)a 35.6(1984)a 36.3(2023)a
Pre-HD care > 3 years+ 28.1(1471)a 35.4(1853)a 36.5(1910)a
Similar letters denote a subset of distance categories whose column
proportions do not differ significantly from each other at the 0.05 level.
* CVC – central venous catheter.
** AVF/AVG – Arteriovenous fistula or arteriovenous graft.
+ limited to patients with any pre-dialysis care.
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partially attenuated by appropriate pre-dialysis care.
Our study is the largest ever undertaken in examining
the specific relationship between type of vascular access
and geographic isolation, which is important because ac-
cess type is such a profound risk modifier. Our data is
consistent with previous reports, many Canadian studies,
illustrating that increased distance, a surrogate marker
for geographic isolation and limited access to health re-
sources, is associated with increases in adverse out-
comes, quality of care and mortality in CKD and ESRD
populations [17-19,28-30].
In our study, the presence and duration of pre-dialysis
care appears to partially mitigate the effect of location
on the likelihood of initiating hemodialysis with a CVC.
Among patients who resided > 20 km from a dialysis
centre, those who received pre-dialysis care for < 1 year
were significantly more likely to commence hemodialysis
with a CVC than their counterparts who received > 1 year
of care. Reduced access to pre-dialysis care in remote
areas is described in other studies as well. A recent study
of 404,602 patients in the US renal data registry showed
that patients in the most rural regions and large metropol-
itan areas were less likely to receive pre-dialysis care > 6 or
12 months, and most likely to receive it if they lived in
small/medium metropolitan areas [31]. SuboptimalTable 2 Adjusted odds ratio of incident usage by distance
from centre
Distance from dialysis centre (km) % CVC (N) OR of incident CVC
<5 78.7(5659) Referent
5-20 78.1(7251) 1.02 (1.00-1.05)
>20 82.3(8202) 1.29 (1.24-1.34)
Distance from centre P < 0.0001 for incident CVC in adjusted models.
Incident CVC adjusted for race, sex, age, BMI, alb, Hb, co-morbidities, cause of
ESRD, any pre-dialysis care, region.
Table 3 Adjusted odds ratios of incident CVC usage by
distance to centre and pre-dialysis care (distance X any





% CVC (N) Adjusted OR of CVC,
no pre-dialysis care
No <5 91.2 (2698) Referent
5-20 89.6 (3557) 1.02 (0.80-1.29)
>20 89.8(3968) 3.64 (2.62-5.07)
Yes <5 70.0 (2961) Referent
5-20 69.5 (3694) 1.21 (1.10-1.34)
>20 76.2 (4234) 2.42 (2.16-2.71)
Models adjusted for race, era, sex, age, BMI, albumin, hemoglobin, co-morbidities,
region, cause of ESRD.
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receive late nephrology care are more likely to start
hemodialysis with a CVC than those referred early to
nephrology [32-36]. In addition, patients commencing
dialysis without adequate duration of pre-dialysis care
are more likely to be anemic, hyperphosphatemic, and
malnourished than those who received longer nephrol-
ogy care before initiation of dialysis [37,38]. Late neph-
rology care is also associated with increased morbidity
and mortality [36-40]. However, the benefit of early re-
ferral is lost if the opportunity to address complica-
tions of CKD and plan for renal replacement therapy is
not utilized to optimize dialysis initiation, as demon-
strated by Hughes et al. in retrospective cohort of 436
hemodialysis patients [41]. In their study, 56% of all pa-
tients that were followed by nephrologists > 12 months
still started hemodialysis with a CVC, in which 65%
started without even an attempt at AVF/AVG creation.
Geographical region played a role in incident vascular
access as patients in the Atlantic and the Central regions
of Canada were more likely to initiate dialysis with a
catheter if they resided > 20 km away from a dialysis
centre. Our findings are consistent with emerging litera-
ture identifying regional differences in vascular access.Table 4 Adjusted odds ratios of incident CVC usage by distan






< 1 year <5 78.4 (941)
5-20 (1) 75.6 (1119)
>20 82.5 (1336)
1-3 years <5 68.6 (1071)
5-20 70.2 (1393)
>20 75.2 (1522)
> 3 <5 64.5 (949)
5-20 63.8 (1182)
>20 72 (1376)
Models adjusted for race, era, sex, age, BMI, albumin, hemoglobin, co-morbidities, rIn a large US study of 10,112 patients across 173 dialysis
facilities, Tangri et al. found after case-mix adjustment, a
large proportion of explainable variability regarding
CVC use was dependent on the treating facility and geo-
graphic regions [25]. Many other aspects of dialysis care
demonstrate regional variability. For example, recent
studies have shown marked variation in cardioprotective
medication prescription [42,43] and kidney transplanata-
tion [44,45] across geographic regions in the United
States that cannot be explained by patient demographics
or burden of comorbidities.
There are several plausible explanations why residence
location may impact vascular access including limited
access to health care resources, reduced access to trans-
portation, especially in rural communities where public
transportation services may be very limited or expensive,
and the time and cost commitments of extensive travel
to centres located far from the home community. The
need to coordinate appointments among multiple spe-
cialists such as vascular surgery, interventional radiology
and nephrology may be additional barriers to timely vas-
cular access assessment and creation. Socioeconomic
status and education level may impact on vascular access
decisions in these patients. In some provinces such as
Manitoba and Saskatchewan, where there are large First
nations population especially in the more rural regions,
language barriers could potentially affect patient deci-
sions regarding vascular access. We have also identified
an area where recognition and interventions targeted at
rural dwellers, such as rapid assessment clinics, may ad-
dress these barriers.
Unfortunately, as highlighted by our study, vascular
access outcomes overall remain fairly poor in Canada.
Although mitigated to some degree by predialysis care,
nearly 80% of all patients starting dialysis do so with a
CVC regardless of whether they live close or far away
from a dialysis centre. This trend has persisted despite
increasing attention towards increasing fistula rates byce to centre and length of pre-dialysis care (distance X
(95% CI) with length of pre-dialysis
care as separate strata
OR (95% CI) with common
referent
Referent Referent
1.19 (0.95-1.48) 0.84 (0.70-1.01)
2.65 (2.05-3.44) 1.27 (1.05-1.54)
referent 0.58 (0.49-0.70)
1.24 (1.05-1.46) 0.63 (0.53-0.75)
2.52 (2.09-3.04) 0.82 (0.69-0.98)
Referent 0.48 (0.40-0.57)
1.21 (1.03-1.41) 0.47 (0.40-0.56)
2.31 (1.93-2.75) 0.71 (0.60-0.84)
egion, cause of ESRD.
Table 5 Adjusted odds ratios of incident CVC usage by
distance to centre and geographic region (distance X
region interaction p = 0.02)
Region Distance from
dialysis centre (km)
% CVC (N) OR 95% CI
Atlantic <5 75.4 (459) Referent
5-20 72.2 (449) 1.19 (0.89-1.61)
> 20 76.4 (1192) 3.05 (2.30-4.04)
Central <5 79.7 (3306) Referent
5-20 79.1 (4320) 1.11 (0.98-1.25)
> 20 85.3 (3962) 2.78 (2.38-3.24)
Prairies <5 78.5 (1173) Referent
5-20 79.1 (1547) 1.50 (1.20-1.88)
> 20 82.1 (2094) 2.06 (1.64-2.59)
Pacific <5 76.5 (721) Referent
5-20 74.9 (935) 1.10 (0.85-1.43)
> 20 78.6 (954) 2.83 (2.06-3.90)
Adjusted for race, era, sex, age, BMI, albumin, hemoglobin, co-morbidities, pre-dialysis
care, cause of ESRD.
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incident patients, Hughes et al. discusses some possible
explanations for catheter use at dialysis initiation, where
patient related delays, acute on chronic renal failure, and
surgical delays accounted for 78% of the reason [41].
Therefore, focused efforts towards these factors may be
a first step in changing incident CVC use, but the find-
ings of our study suggests there may be unique patient
characteristics in the rural population that may still war-
rant a different approach.
The strengths of our study include a large, representa-
tive, national cohort with accurate ascertainment of expo-
sures and outcomes. We also performed comprehensive
case mix adjustment for multiple factors, including demo-
graphics, comorbidities, and laboratory variables thereby
accounting for patient related factors that may impact dia-
lysis access. Furthermore, although we used multiple im-
putation for missing values, separate models were created
using original and imputed data, and no significant differ-
ences were seen. Lastly, although we chose access type at
initiation of dialysis, we only included those patients still
on hemodialysis at 90 days, which we felt strengthened
our analysis because it removed the acute dialysis starts
who recover kidney function or die in the first 90 days,
and chronic dialysis patients who convert to peritoneal
dialysis or undergo renal transplantation within the first
90 days. Although this may introduce survival bias, it
would be less likely to overestimate the catheter patients
who may have started dialysis with a CVC for a well-
defined reason (eg/acute unexpected renal deterioration
in someone planning PD as definitive renal replacement
modality).There are some limitations to our study. Distance to
centre was determined by postal code, and may not re-
flect true travel distance or the degree of isolation. For
example, two communities located the same distance
from a dialysis centre may vary widely in that one might
be a fly-in community while the other has a well-
established road system. In addition, our analysis calcu-
lated distance from postal code to closest dialysis centre,
which for some patients may have differed from the ac-
tual dialysis centre of first hemodialysis. Since the cutoff
for furthest distance was > 20 km, there is likely signifi-
cant heterogeneity in this population. The availability of
health care resources may vary widely in that some indi-
viduals may have access to hospitals, specialists, and im-
aging services while others may only have access to a
nursing station. Our study does not account for factors
related directly to vascular access creation such as surgi-
cal assessment, operating room wait times, patient deci-
sion, patient suitability for AVF/G creation, and history
of failed AVF/G. Since low rates of AVF creation, AVF
with delayed maturation and failure to mature are all
possible explanations contributing to our results, access
creation rate would have been valuable but this informa-
tion is not available in the CORR database. Furthermore,
distance to dialysis centre may not necessarily correlate
with distance to pre-dialysis care, where the referral
and/or surgical creation of an AVF/AVG would occur.
Our data also does not account for patient mobility,
where a patient may have relocated from a more remote
location to one that is in closer proximity to their neph-
rology care, thus potentially introducing error in the dis-
tance classification for those patients. Lastly, our results
could have been confounded by other unmeasured fac-
tors (e.g. socioeconomic) that are not collected in the
CORR database.
Conclusions
In summary, we found that increasing residential distance
from a dialysis centre was associated with increased use of
CVC in incident dialysis patients. This association was
mitigated but not eliminated by exposure to adequate pre-
dialysis care. Additional efforts to address geographic dis-
parities in dialysis care are needed.
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